Palogic Value Management L.P. Buys Shares of 120,177 Phreesia, Inc. $PHR

Palogic Value Management L.P. purchased a new position in Phreesia, Inc. (NYSE:PHR) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 120,177 shares of the company’s stock, valued at approximately $1,237,000. Palogic Value Management L.P. owned about 0.19% of Phreesia at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Van ECK Associates Corp boosted its position in shares of Phreesia by 78.7% in the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares in the last quarter. Rockefeller Capital Management L.P. increased its position in Phreesia by 354.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after buying an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in Phreesia by 1,119.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after buying an additional 3,001 shares in the last quarter. Garner Asset Management Corp purchased a new stake in Phreesia in the fourth quarter valued at about $81,000. Finally, New York State Teachers Retirement System purchased a new stake in Phreesia in the first quarter valued at about $44,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Price Performance

Shares of PHR opened at $11.58 on Thursday. The business’s 50-day moving average is $10.92 and its two-hundred day moving average is $10.49. The company has a market capitalization of $715.78 million, a P/E ratio of 77.20 and a beta of 0.85. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. The business had revenue of $130.94 million during the quarter, compared to analysts’ expectations of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.07) EPS. Research analysts predict that Phreesia, Inc. will post 0.39 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on PHR. Wall Street Zen upgraded Phreesia from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research report on Friday, May 29th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $9.00 target price (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. Piper Sandler downgraded shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price on the stock. in a research report on Thursday, May 28th. Finally, Truist Financial raised their price target on shares of Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a report on Thursday, May 28th. Nine research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Phreesia presently has a consensus rating of “Hold” and a consensus target price of $16.65.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.